Skip to main content
PMC home page
The Journal of Experimental Medicine logoLink to The Journal of Experimental Medicine
. 1992 Apr 1;175(4):1081–1090. doi: 10.1084/jem.175.4.1081

The insulin-like growth factor I receptor is overexpressed in psoriatic epidermis, but is differentially regulated from the epidermal growth factor receptor

PMCID: PMC2119176  PMID: 1313074

Abstract

Insulin-like growth factor I (IGF-I)/somatomedin C is an important mediator of keratinocyte growth in vitro, and the expression of IGF-I receptors in the basal layer of normal epidermis suggests that this growth pathway may function in the regulation of keratinocyte growth in vivo as well. The pattern of IGF-I receptor expression in normal skin is distinct from that of the epidermal growth factor (EGF) receptor, suggesting that these receptors might be differentially regulated. The purpose of this study was to obtain a better understanding of IGF-I receptor function in the skin by examining IGF-I receptor expression in psoriatic epidermis and in cultured human keratinocytes. Our findings indicate that IGF-I receptor expression is increased in psoriasis as measured by protein tyrosine kinase assays of biopsy extracts and by immunohistochemical staining with an IGF-I receptor-specific monoclonal antibody. Unlike EGF receptor expression, which is also increased in psoriatic epidermis, the pattern of IGF-I receptor expression corresponds closely with the increased size of the keratinocyte proliferative compartment in psoriasis. Biochemical agents that diminish EGF receptor ligand binding (phorbol ester or calcium ionophore treatment) produce opposite effects on the IGF-I receptor. These results suggest that cellular expression and differential regulation of both growth factor receptor systems may control critical aspects of epidermal proliferation or function.

Full Text

The Full Text of this article is available as a PDF (1.6 MB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Braverman I. M., Yen A. Ultrastructure of the human dermal microcirculation. II. The capillary loops of the dermal papillae. J Invest Dermatol. 1977 Jan;68(1):44–52. doi: 10.1111/1523-1747.ep12485165. [DOI] [PubMed] [Google Scholar]
  2. Camisa C. Somatostatin and a long-acting analogue, octreotide acetate. Relevance to dermatology. Arch Dermatol. 1989 Mar;125(3):407–412. [PubMed] [Google Scholar]
  3. Catanese V. M., Grigorescu F., King G. L., Kahn C. R. The human erythrocyte insulin-like growth factor I receptor: characterization and demonstration of ligand-stimulated autophosphorylation. J Clin Endocrinol Metab. 1986 Apr;62(4):692–699. doi: 10.1210/jcem-62-4-692. [DOI] [PubMed] [Google Scholar]
  4. Czech M. P. Signal transmission by the insulin-like growth factors. Cell. 1989 Oct 20;59(2):235–238. doi: 10.1016/0092-8674(89)90281-x. [DOI] [PubMed] [Google Scholar]
  5. Davis R. J. Independent mechanisms account for the regulation by protein kinase C of the epidermal growth factor receptor affinity and tyrosine-protein kinase activity. J Biol Chem. 1988 Jul 5;263(19):9462–9469. [PubMed] [Google Scholar]
  6. Elder J. T., Fisher G. J., Lindquist P. B., Bennett G. L., Pittelkow M. R., Coffey R. J., Jr, Ellingsworth L., Derynck R., Voorhees J. J. Overexpression of transforming growth factor alpha in psoriatic epidermis. Science. 1989 Feb 10;243(4892):811–814. doi: 10.1126/science.2916128. [DOI] [PubMed] [Google Scholar]
  7. Furlanetto R. W., DiCarlo J. N., Wisehart C. The type II insulin-like growth factor receptor does not mediate deoxyribonucleic acid synthesis in human fibroblasts. J Clin Endocrinol Metab. 1987 Jun;64(6):1142–1149. doi: 10.1210/jcem-64-6-1142. [DOI] [PubMed] [Google Scholar]
  8. Gentleman S., Martensen T. M., Digiovanna J. J., Chader G. J. Protein tyrosine kinase and protein phosphotyrosine phosphatase in normal and psoriatic skin. Biochim Biophys Acta. 1984 Mar 22;798(1):53–59. doi: 10.1016/0304-4165(84)90009-6. [DOI] [PubMed] [Google Scholar]
  9. Gottlieb A. B., Chang C. K., Posnett D. N., Fanelli B., Tam J. P. Detection of transforming growth factor alpha in normal, malignant, and hyperproliferative human keratinocytes. J Exp Med. 1988 Feb 1;167(2):670–675. doi: 10.1084/jem.167.2.670. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Green M. R., Couchman J. R. Differences in human skin between the epidermal growth factor receptor distribution detected by EGF binding and monoclonal antibody recognition. J Invest Dermatol. 1985 Sep;85(3):239–245. doi: 10.1111/1523-1747.ep12276708. [DOI] [PubMed] [Google Scholar]
  11. Hansson H. A., Jonsson R., Petruson K. Transiently increased insulin-like growth factor. I. Immunoreactivity in UVB-irradiated mouse skin. J Invest Dermatol. 1988 Oct;91(4):328–332. doi: 10.1111/1523-1747.ep12475660. [DOI] [PubMed] [Google Scholar]
  12. Jacobs S., Cook S., Svoboda M. E., Van Wyk J. J. Interaction of the monoclonal antibodies alpha IR-1 and alpha IR-3 with insulin and somatomedin-C receptors. Endocrinology. 1986 Jan;118(1):223–226. doi: 10.1210/endo-118-1-223. [DOI] [PubMed] [Google Scholar]
  13. Krane J. F., Murphy D. P., Carter D. M., Krueger J. G. Synergistic effects of epidermal growth factor (EGF) and insulin-like growth factor I/somatomedin C (IGF-I) on keratinocyte proliferation may be mediated by IGF-I transmodulation of the EGF receptor. J Invest Dermatol. 1991 Apr;96(4):419–424. doi: 10.1111/1523-1747.ep12469799. [DOI] [PubMed] [Google Scholar]
  14. Krane J. F., Murphy D. P., Gottlieb A. B., Carter D. M., Hart C. E., Krueger J. G. Increased dermal expression of platelet-derived growth factor receptors in growth-activated skin wounds and psoriasis. J Invest Dermatol. 1991 Jun;96(6):983–986. doi: 10.1111/1523-1747.ep12476485. [DOI] [PubMed] [Google Scholar]
  15. Kull F. C., Jr, Jacobs S., Su Y. F., Svoboda M. E., Van Wyk J. J., Cuatrecasas P. Monoclonal antibodies to receptors for insulin and somatomedin-C. J Biol Chem. 1983 May 25;258(10):6561–6566. [PubMed] [Google Scholar]
  16. Lammers R., Gray A., Schlessinger J., Ullrich A. Differential signalling potential of insulin- and IGF-1-receptor cytoplasmic domains. EMBO J. 1989 May;8(5):1369–1375. doi: 10.1002/j.1460-2075.1989.tb03517.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Massagué J., Czech M. P. The subunit structures of two distinct receptors for insulin-like growth factors I and II and their relationship to the insulin receptor. J Biol Chem. 1982 May 10;257(9):5038–5045. [PubMed] [Google Scholar]
  18. Misra P., Nickoloff B. J., Morhenn V. B., Hintz R. L., Rosenfeld R. G. Characterization of insulin-like growth factor-I/somatomedin-C receptors on human keratinocyte monolayers. J Invest Dermatol. 1986 Aug;87(2):264–267. doi: 10.1111/1523-1747.ep12696645. [DOI] [PubMed] [Google Scholar]
  19. Nanney L. B., Stoscheck C. M., Magid M., King L. E., Jr Altered [125I]epidermal growth factor binding and receptor distribution in psoriasis. J Invest Dermatol. 1986 Mar;86(3):260–265. doi: 10.1111/1523-1747.ep12285389. [DOI] [PubMed] [Google Scholar]
  20. Nickoloff B. J., Misra P., Morhenn V. B., Hintz R. L., Rosenfeld R. G. Further characterization of the keratinocyte somatomedin-C/insulin-like growth factor I (SM-C/IGF-I) receptor and the biological responsiveness of cultured keratinocytes to SM-C/IGF-I. Dermatologica. 1988;177(5):265–273. doi: 10.1159/000248577. [DOI] [PubMed] [Google Scholar]
  21. Pardee A. B. G1 events and regulation of cell proliferation. Science. 1989 Nov 3;246(4930):603–608. doi: 10.1126/science.2683075. [DOI] [PubMed] [Google Scholar]
  22. Pfeifle B., Ditschuneit H. Two separate receptors for insulin and insulinlike growth factors on arterial smooth muscle cells. Exp Clin Endocrinol. 1983 May;81(3):280–286. doi: 10.1055/s-0029-1210237. [DOI] [PubMed] [Google Scholar]
  23. Ristow H. J., Messmer T. O. Basic fibroblast growth factor and insulin-like growth factor I are strong mitogens for cultured mouse keratinocytes. J Cell Physiol. 1988 Nov;137(2):277–284. doi: 10.1002/jcp.1041370210. [DOI] [PubMed] [Google Scholar]
  24. Rosenfeld R. G., Dollar L. A. Characterization of the somatomedin-C/insulin-like growth factor I (SM-C/IGF-I) receptor on cultured human fibroblast monolayers: regulation of receptor concentrations by SM-C/IGF-I and insulin. J Clin Endocrinol Metab. 1982 Sep;55(3):434–440. doi: 10.1210/jcem-55-3-434. [DOI] [PubMed] [Google Scholar]
  25. Stewart A. J., Johnson M. D., May F. E., Westley B. R. Role of insulin-like growth factors and the type I insulin-like growth factor receptor in the estrogen-stimulated proliferation of human breast cancer cells. J Biol Chem. 1990 Dec 5;265(34):21172–21178. [PubMed] [Google Scholar]
  26. Ullrich A., Gray A., Tam A. W., Yang-Feng T., Tsubokawa M., Collins C., Henzel W., Le Bon T., Kathuria S., Chen E. Insulin-like growth factor I receptor primary structure: comparison with insulin receptor suggests structural determinants that define functional specificity. EMBO J. 1986 Oct;5(10):2503–2512. doi: 10.1002/j.1460-2075.1986.tb04528.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. VANSCOTT E. J., EKEL T. M. KINETICS OF HYPERPLASIA IN PSORIASIS. Arch Dermatol. 1963 Oct;88:373–381. [PubMed] [Google Scholar]
  28. Werner H., Stannard B., Bach M. A., LeRoith D., Roberts C. T., Jr Cloning and characterization of the proximal promoter region of the rat insulin-like growth factor I (IGF-I) receptor gene. Biochem Biophys Res Commun. 1990 Jun 29;169(3):1021–1027. doi: 10.1016/0006-291x(90)91996-6. [DOI] [PubMed] [Google Scholar]
  29. Werner H., Woloschak M., Adamo M., Shen-Orr Z., Roberts C. T., Jr, LeRoith D. Developmental regulation of the rat insulin-like growth factor I receptor gene. Proc Natl Acad Sci U S A. 1989 Oct;86(19):7451–7455. doi: 10.1073/pnas.86.19.7451. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

RESOURCES